In addition, TNR has been identified as a tumor-associated ECM protein with roles in cell adhesion, invasion, and immune evasion, and given its restricted expression in the central nervous system and involvement in glioma progression, it has been identified as a potential immunotherapy target59. Here, TNR is linked to central nervous system cancer.